Clinique Paris Bercy
Charenton-le-Pont, F-94220, France
NCT Number: NCT04251013
The aim of this prospective national multicenter randomized study is to compare, during an ERCP for VBP stenosis, the sensitivity of two biliary brushes: the INFINITY® vs the RX Cytology Brush® The main objective is the comparison of the rates of positive diagnosis of biliary brushing in cases of adenocarcinoma stenosis The total number of subjects required: 50 (25 patients per group) Duration of the inclusion period: 2 years Duration of participation for each subject: from 7 days to 12 months (in case of negative initial withdrawal) Total duration of the study: 3 years
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Charenton-le-Pont, F-94220, France
The aim of this study is to compare, during an ERCP for VBP stenosis, the sensitivity of two biliary brushes: the INFINITY® vs the RX Cytology Brush®
OBJECTIVES
This study concerns adult subjects with stenosis of the main bile duct (common bile duct or common hepatic duct).
ENDOSCOPIC PROCEDURE
All possible sampling methods will also be taken to obtain the anatomopathological diagnosis: intra-biliary biopsies with adult or pediatric forceps, wire-guided or not, biopsy samples guided by choledochoscopy, puncture under endo-ultrasonography, bile aspiration after release of the biliary stent, according to the physician's habits.
EFFECTIVE The total number of subjects required: 50 (25 patients per group) Duration of the inclusion period: 2 years Duration of participation for each subject: from 7 days to 12 months (in case of negative initial withdrawal) Total duration of the study: 3 years
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Biliary brushing during ERCP:
Biliary brushing during ERCP:
Time frame: 8 days to 1 year (if negative)
Rate of positive diagnosis of biliary brushing in case of cholangiocarcinoma stenosis
Time frame: 8 days
Quantification of the cellular material obtained (acellular, weak, or abundant), presence of cellular cupboards unhooked by the brush or average number of cells per field
Time frame: 1 year
Negative brushing for a final diagnosis of cholangiocarcinoma
Time frame: 1 year
probability that patients with a negative brushing truly don't have cholangiocarcinoma
Time frame: 1 day
Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)
Time frame: 1 day
Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)
Time frame: 1 day
Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)
Time frame: 1 day
Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)
Société Française d'Endoscopie Digestive
Other
Multicenter RCT Comparing Two Brushes of Different Diameters for Biliary Stenosis: RX Cytology Brush, BOSTON vs. Infinity® Brush, US Endoscopy. BIB Study (BIliary Brushing)
Acronym: BIB
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05556668
Bile Duct Injury, Bile Duct Stricture
Sabadell, Spain
View Trial DetailsNCT03977779
Bile Duct Diseases, Biliary Dyskinesia
Marseille, Provence-Alpes-Côte d'Azur Region, France
View Trial DetailsNCT04572711
Adenocarcinoma, Biliary Stricture
Rochester, Minnesota, United States
View Trial DetailsNCT05826639
Bile Duct Diseases, Biliary Stricture
Rochester, Minnesota, United States
View Trial Details